[Pharmaceutical Therapy for the Severe Hemodynamic Depression with Carotid Artery Stenting].

Min Yang,Li Song,Jian Wang,Xiao-qiang Tong,Ying-hua Zou
DOI: https://doi.org/10.3969/j.issn.1671-167x.2009.03.027
2009-01-01
Abstract:OBJECTIVE:To evaluate the efficacy of pharmaceutical therapy for the severe hemodynamic depression with carotid artery stenting(CAS).METHODS:Clinical data were retrospectively analyzed on CAS over the last 5 years. Severe hemodynamic depression was defined as periprocedural hypotension (blood pressure <90/60 mmHg) or bradycardia (heart rate <50 beats/min) persisting for at least 1 hour. 13 patients were included in the research.RESULTS:Dopamine was pumped intravenously in all the 13 patients .The dose was from 2 microg/min/kg to 10 microg/min/kg, the duration was from 4 to 48 hours. Dobutamine was used in 2 patients and dose from 5 microg/min/kg to 7 microg/min/kg, duration was from 24 to 36 hours. None of the patients developed any permanent neurological complications. One acute coronary syndrome occured during the postprocedure period.CONCLUSION:Severe hemodynamic depression can be controlled with vasopressors (dopamine or dobutamine) and the associated complications can be prevented.
What problem does this paper attempt to address?